Our Amsterdam facility produces early clinical trial material alongside our research and process development labs. There we focus on the production of GMP starting material, including cell banking and seed viruses.
Our facility in Lexington, Massachusetts, is one of the largest, most versatile gene therapy manufacturing facilities in the world. uniQure has made significant investments in designing, constructing and equipping our facility with state-of-the-art laboratories and commercial-scale production capabilities. The facility, which was expanded in late 2019 from 55,000 square feet to 86,000 square feet, offers GMP production capabilities to support all of our existing programs, with flexibility to expand further.
Our Lexington commercial facility is fully GMP approved by the FDA and other health regulatory agencies around the world, including Europe and Canada.
